• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners

    9/16/25 10:30:00 AM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email

    NEW YORK, Sept. 16, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global connected health market is observing significant growth due to the increasing prevalence of chronic diseases, rising emphasis on preventive healthcare, and advancements in medical technology.

    The_Insight_Partners_Logo

    The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the connected health market comprises a vast array of product types, applications, and end users, which are expected to register strength in the coming years.

    Therefore, the report from The Insight Partners provides several stakeholders—including raw material/component provider, connected health market manufacturers, government agencies, regulatory bodies, and end users —valuable insights into navigating this evolving market landscape and successfully unlocking new opportunities.

    Check valuable insights in the Connected Health Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPRE00002975

    Overview of Report Findings

    1. Market Growth: The increasing prevalence of chronic diseases, rising emphasis on preventive healthcare, and advancements in medical technology are a few of the significant factors driving the global connected health market. Furthermore, AI and predictive analytics in healthcare, AI and predictive analytics in healthcare, and the rise of smart hospitals and edge computing will likely propel the demand for connected health in the future.
    2. Increasing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases stands as a pivotal driver for the growth of the connected health market. Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders require continuous monitoring and management to prevent complications and hospitalizations. Connected Health solutions, which integrate digital tools, remote monitoring devices, and telehealth services, offer a seamless approach to managing these long-term illnesses by enabling real-time tracking and personalized care outside traditional clinical settings. For patients living with chronic diseases, consistent engagement with healthcare providers and adherence to treatment regimens are crucial.

      Connected health platforms facilitate this by providing timely feedback and alerts, thus empowering patients to take proactive steps in managing their health. For example, continuous glucose monitoring systems connected to mobile apps allow diabetic patients to monitor blood sugar levels throughout the day, helping to reduce the risk of acute events such as hypoglycemia or hyperglycemia. Similarly, remote cardiac monitors enable physicians to track arrhythmias or heart failure symptoms in real time, allowing for early intervention before conditions worsen. As chronic diseases become more widespread globally, the demand for connected health solutions will continue to surge. These technologies support better disease management and patient engagement and alleviate the strain on healthcare infrastructure, positioning Connected Health as an indispensable component of future healthcare delivery.
    3. Advancements in Medical Technology: Advancements in medical technology play a pivotal role in driving the growth of the connected healthcare market. As healthcare shifts towards a more patient-centric approach, innovative medical devices and digital solutions enable seamless integration of health data, remote monitoring, and real-time communication between patients and healthcare providers. These technological improvements enhance the accuracy, efficiency, and accessibility of healthcare services, making connected healthcare viable and essential for modern medical practice.

      For instance, the development of wearable health devices, such as continuous glucose monitors and smart heart rate trackers, allows for constant health monitoring outside clinical settings. These devices collect critical health metrics and transmit them to healthcare professionals, enabling timely interventions and personalized treatment plans.

      Integrating artificial intelligence (AI) and machine learning algorithms further refines this process by analyzing large datasets to predict health trends and identify potential risks early. The FDA's clearance of AI-powered diagnostic tools, such as IDx-DR for diabetic retinopathy detection, demonstrates how advanced medical technology is being directly embedded into connected healthcare systems to improve patient outcomes.

      Continuous innovation in medical technology fosters the development of new connected healthcare solutions and enhances the overall delivery and quality of care. These advancements are key drivers, transforming healthcare systems worldwide into more integrated, efficient, and patient-friendly networks.
    4. Geographical Insights: In 2024, Asia Pacific led the market with a substantial revenue share, followed by North America and Europe.

    Get Research Sample Copy of the Connected Health Market: https://www.theinsightpartners.com/sample/TIPRE00002975

    Market Segmentation

    • On the basis of Product Type, the global connected health market is segmented into M-Health Devices and M-Health Services. The M-Health Services segment dominated the market in 2024.
    • By Application, the global connected health market is segmented into Monitoring Application, Diagnostic and Treatment, Healthcare Management, Wellness and Prevention, and Others. The Diagnosis and Treatment segment held the largest share of the connected health in 2024.
    • In terms of End User, the global connected health market is segmented into Hospitals and Clinics, Home Monitoring and Others. The Home Monitoring segment dominated the market in 2024.

    Competitive Strategy and Development

    • Key Players: Koninklijke Philips, Apple Inc., OMRON Corp., International Business Machines Corp., Abbott Laboratories, Medtronic Plc, GE HealthCare Technologies Inc., Fitbit LLC, Boston Scientific Corp, and Samsung Electronics Co. are among the key players profiled in the connected health market report.



    • Trending Topics: Smart and Wearable Health Devices, Predictive Health, Remote Patient Monitoring among others

    Global Headlines

    • GE HealthCare (NASDAQ:GEHC) has topped a US Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the US This milestone reflects GE HealthCare's continued research and development (R&D) investment and focus on developing AI solutions to advance precision care by enhancing medical devices across the care journey. Smart devices, software, and cloud-based solutions, which are central to GE HealthCare's precision care strategy, help enhance patient outcomes, improve care teams' daily work, and boost healthcare professionals' efficiency. These AI-enabled devices help solve customer challenges and are in high demand, which contributes to orders, revenue, and growth for the company."



    • Abbott Laboratories had announced that it had partnered with Women as One to launch a new program. The program is designed to train more female and underrepresented physicians to pursue clinical trial research. It aims to help recruit clinical trial participants from historically underrepresented groups. Abbott provided funds to develop a CLIMB Research program, which provides skills training for underrepresented cardiologists. The program is built on Abbott's diversity in clinical trials initiative, which was established in 2021 to develop and create a more inclusive clinical trial ecosystem in the US."

    Get Premium Copy of Connected Health Market Size and Growth Report by 2031 at:  https://www.theinsightpartners.com/buy/TIPRE00002975

    Conclusion

    Connected health is an integrated healthcare delivery model that leverages digital technology to provide patient-centered care across settings, including hospitals, homes, and remote locations. It encompasses technologies such as telemedicine, mHealth (mobile health), remote patient monitoring, wearable devices, and electronic health records (EHRs). These systems allow real-time communication between patients and healthcare providers, promoting proactive care, early intervention, and improved health outcomes.

    Key benefits include enhanced access to care, reduced healthcare costs, improved chronic disease management, and increased patient engagement. Applications span across chronic disease monitoring, post-acute care, elderly care, fitness tracking, mental health, and preventive care. Connected health solutions can be categorized into telehealth platforms, wearable health devices, software solutions, and health information exchange systems.

    Trending Related Reports:

    • Digital Health Market Forecast 2025-31 |Trends & Key Players
    • Home Healthcare Market Forecast, Trends, Scope by 2031
    • Farm Animal Healthcare Market Size & CAGR (2025-2031)
    • Healthcare Data Monetization Market Findings and Share – 2031
    • Digestive Health Enzymes Market Opportunities by 2031
    • Healthcare Fabrics Market Growth and Share by 2031
    • Blockchain Technology Healthcare Market Overview by 2031
    • Electronic Health Record Market Size, Growth & Trends 2031

    About Us:

    The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

    Contact Us:

    If you have any queries about this report or if you would like further information, please get in touch with us:

    Contact Person: Ankit Mathur

    E-mail: [email protected]

    Phone: +1-646-491-9876

    Also Available in : 한국어 | Deutsch | 日本 | Français | لعربية | 中文 | Italiano | Español

    Logo: https://mma.prnewswire.com/media/1586348/5449703/The_Insight_Partners_Logo.jpg

     

    Cision View original content:https://www.prnewswire.com/news-releases/connected-health-market-is-projected-to-reach-us421-5-billion-by-2031-with-cagr-of-6-5-during-20252031--the-insight-partners-302557607.html

    SOURCE The Insight Partners

    Get the next $GEHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    9/9/2024$90.00Neutral
    JP Morgan
    8/6/2024$100.00Buy
    Stifel
    5/30/2024$87.00Neutral
    Goldman
    More analyst ratings

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, Imaging Rott Roland covered exercise/tax liability with 4,620 shares and exercised 5,341 shares at a strike of $55.91, increasing direct ownership by 3% to 29,122 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    9/12/25 4:05:10 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Chief Enterprise Oper. Officer Stacherski Kenneth R. covered exercise/tax liability with 892 shares, decreasing direct ownership by 2% to 40,996 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    9/3/25 4:19:36 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Chief People Officer Holton Adam Y covered exercise/tax liability with 464 shares, decreasing direct ownership by 3% to 16,768 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    9/3/25 4:18:39 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    5/2/24 6:00:38 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GE HealthCare upgraded by UBS with a new price target

    UBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $73.00

    5/5/25 8:34:55 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare upgraded by Goldman with a new price target

    Goldman upgraded GE HealthCare from Neutral to Buy and set a new price target of $100.00 from $85.00 previously

    3/11/25 7:35:30 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare upgraded by Jefferies with a new price target

    Jefferies upgraded GE HealthCare from Hold to Buy and set a new price target of $103.00 from $95.00 previously

    1/8/25 7:50:38 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025

    Early adopters of Intelligent Radiation Therapy (iRT) to date have reduced simulation to treatment planning time from seven days to seven minutes1 via integration with RayStation® by RaySearch Laboratories The new version of iRT enhances connectivity, uses insights to improve efficiency, and includes a solution to manage workflows for the emerging field of theranostics GE HealthCare will spotlight its comprehensive radiation oncology portfolio at its booth, underscoring the company's commitment to accelerating global access to radiation therapy GE HealthCare (NASDAQ: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company's software solut

    9/25/25 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare announces cash dividend for third quarter of 2025

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14, 2025 to all shareholders of record as of October 24, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for

    9/24/25 3:58:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

    BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.  (NASDAQ:LNTH) and GE HealthCare (NASDAQ:GEHC) today announced an exclusive licensing agreement for GE HealthCare to develop, manufacture, and commercialize Lantheus' piflufolastat F18 (PYLARIFY® in U.S. market) in Japan for prostate cancer diagnostics and companion diagnostic use. PYLARIFY is used for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. The agreement includes the transfer of regulatory dossiers, manufacturing competencies and technical support to enable GE HealthCare to drive clinical development

    9/24/25 1:00:00 AM ET
    $GEHC
    $LNTH
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    $GEHC
    SEC Filings

    View All

    SEC Form 144 filed by GE HealthCare Technologies Inc.

    144 - GE HealthCare Technologies Inc. (0001932393) (Subject)

    9/22/25 4:44:03 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form 144 filed by GE HealthCare Technologies Inc.

    144 - GE HealthCare Technologies Inc. (0001932393) (Subject)

    9/12/25 4:47:37 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SCHEDULE 13G filed by GE HealthCare Technologies Inc.

    SCHEDULE 13G - GE HealthCare Technologies Inc. (0001932393) (Subject)

    8/13/25 4:35:15 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    View All

    PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

    BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025. Mr. Montagut brings over 25 years of senior leadership experience in the pharmaceutical sector, with a solid track record of driving growth and executing strategic transformation across glob

    6/2/25 8:00:00 AM ET
    $GEHC
    $LNTH
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

    GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

    4/9/25 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

    Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta's radiation therapy offerings with GE HealthCare's MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta's existing global commercial collaboration agreement, which enables the two companies to provide hospitals and cancer patients a comprehensive radiation therapy offering across imaging and treatment Weeks after closing its acquisition of MIM Software – a global provider of medical imaging analy

    4/22/24 7:07:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Financials

    Live finance-specific insights

    View All

    GE HealthCare announces cash dividend for third quarter of 2025

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14, 2025 to all shareholders of record as of October 24, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for

    9/24/25 3:58:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare reports second quarter 2025 financial results

    Revenue growth was 3% year-over-year; Organic revenue growth* was 2% Net income margin was 9.7% versus 8.9% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 14.6% versus 15.3% Diluted earnings per share (EPS) were $1.06 versus $0.93 for the prior year; Adjusted EPS* was $1.06 versus $1.00 Cash flow from operating activities was $94 million versus $(119) million for the prior year; Free cash flow* was $7 million versus $(182) million Raises full-year 2025 guidance GE HealthCare (NASDAQ:GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, "We were pleas

    7/30/25 6:20:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare to announce second quarter 2025 results on July 30, 2025

    GE HealthCare (NASDAQ:GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical techno

    7/7/25 8:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    11/12/24 12:53:28 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    10/22/24 4:16:16 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    4/2/24 4:07:29 PM ET
    $GEHC
    Medical Electronics
    Health Care